Cancer Conferences | Cancer Research | Medicinal Cancer Research Conferences | Conferenceseries

Renowned Speakers

Cancer Conferences, Cancer Research 2024, International Cancer conferences, Oncology Conferences , Cancer Therapy Meetings, World Cancer Conferences, Cancer Research Conferences , Cancer webinars Europe, Oncologists Conferences, International cancer conferences, European Online cancer conferences

Vitor H. Pomin

Federal University of Rio de Janeiro Brazil

Adrian Senderowicz

Cerulean Pharma USA

Nikhil Mukhi

SUNY Downstate Medical Center USA

Niccola Funel

University of Pisa Italy

Jianchang Yang

Stony Brook University Medical Center China

B R Das

Research and Development, SRL Ltd. India

Vincent Balaya

University Paris Descartes France

Xudong Miao

Zhejiang University China

Recommended Global Medical Webinars & Conferences

Europe & UK

Hematology Congress 2024, UK Copd 2023, Netherlands Oncology 2024, Switzerland

Asia Pacific & Middle East

Cancer Care 2023, Malaysia Pharmacology-Toxicology 2023, Japan Infectious Meet 2023, Singapore

Canada

Oncology And Radiology 2023, Canada Pediatric Oncology Conference 2023, Canada

Cancer Research 2024

About Conference

The 20^th international conference on Cancer Research is scheduled for March 18-19, 2024 Zurich, Switzerland organized in collaboration with generous support and cooperation from enthusiastic academicians and editorial Board Members. Cancer Research 2024 aims at sharing new ideas and technologies amongst the professionals, industrialists and students from research areas of Cance Prevention & Research. As the premier event, we have developed a program with your interests in mind. We have not only increased the number of opportunities for you to network with colleagues from across the world but also introduced more focused sessions that will feature cutting edge presentations, special panel discussions, and livelier interaction with industry leaders and experts. Cancer Research 2024 is a remarkable occasion intended for International therapeutic well being experts, Pharmacologists and oncologists to encourage the spread and utilization of research discoveries identified with Cancer.

The Cancer Research Conference welcomes members from every single driving college, clinical research foundations and demonstrative organizations to share their exploration encounters on all parts of this quickly extending field and in this manner, giving a grandstand of the most recent method.All inclusive Cancer growth has a significant wellbeing sway over the general public, new instances of tumours are analysed and detailed every single year. Starting a year ago (2018) 17 million new instances of Cancer growth were accounted for and the passing cases were 9.6 million.Cancer conferences aim at collaborative research among the experts worldwide. Along with new innovations for treatment and diagnosis, it also envisages to bring out cancer research for a sustainable treatment and diagnosis worldwide.This cancer conference has been designed based on the latest advanced research in cancer with a purpose to gather expert oncologist, scientist, academicians, students and other multidisciplinary researchers in the arena of cancer.

Young Scientist Benefits

Our conferences provide best Platform for your research through oral presentations.
Share the ideas with both eminent researchers and mentors.
Young Scientist Award reorganization certificate and memento to the winners
Young Scientists will get appropriate and timely information by this Forum.
Platform for collaboration among young researchers for better development

Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.

Sessions/Tracks

Track 1: Cancer Epidemiology, Screening, Diagnosis & Prognosis

The Epidemiology of Cancer is the investigation of the components influencing Cancer, an approach to finish up potential inclinations and causes. The investigation of Cancer Epidemiology rehearses Epidemiological Methods to find the reason for Cancer and to perceive and create upgraded medicines. This degree of concentrate must adapt to challenges of lead time predisposition and length time inclination. Lead time inclination is the hypothesis that essential conclusion may falsely expand the endurance measurements of a Cancer, without really improving the characteristic history of the illness. Length predisposition is the idea that delicate developing, progressively torpid Tumors are bound to be perceived by Screening Tests, yet upgrades in diagnosing more instances of lethargic Cancer may not convert into better patient results after the execution of Screening Programs.
Most Cancers are initially known either in light of the presence of signs or indications or through Screening. Neither of these prompts a Definitive Diagnosis, which involves the assessment of a tissue test by a pathologist. Individuals with suspected Cancer are seen with medicinal tests. These for the most part incorporate Blood Tests, CT Scans, X-beams and Endoscopy.
Screenings can discover introductory Cancer, when it's generally reparable. Disease Screening means to recognize Cancer before manifestations show up. This may incorporate blood tests, pee tests, different tests, or Medical Imaging.

Microfluidic device for cancer screening
Cancer Staging
Early detection and diagnosis of Cancer
Circulating tumor cells (CTCs) towards cancer Diagnosis
Cohort studies and Cancer Survival analysis

European Cancer Societies: Children's Cancer Association, French Society of Oncology Pharmacy, French Society of Oncology Pharmacy, Belgian Association of Oncological Radiotherapy, Cancer Registry Bavaria, European Cancer Organization.

USA Cancer Societies: National Cancer Institute, American Childhood Cancer Association, National Brain Tumor Society, American Cancer Society, Gynecologic Oncology Group.

Organ Specific Cancer is usually named based on the location of the Cancer cell in the body organ. There are more than 100 types of Cancer and it may occur anywhere in the human body. Breast Cancer is most common in Women, and Prostate cancer is common in Men. Lung cancer and colorectal cancer occurs commonly in both men and women. Cancer also defined by the type of the cell formed them, like epithelial or squamous cell. There are different types of Cancers based on location of cancer in the body organ. These types of Malignancies come under the category of Organ Specific Cancer.

Breast Cancer
Lung Cancer
Prostate Cancer
Ovary Cancer
Non Hodgkin Lymphoma
And Others

European Cancer Societies: Dutch Society for Surgical Oncology, German Society of Radiation Oncology, Childhood Cancer Research Group, Association of Population-based Cancer Registries in Germany, French Society of Radiation Oncology,

USA Cancer Societies: Colon Cancer Alliance, American Childhood Cancer Association, American Society for Radiation Oncology, Children's Neuroblastoma Cancer Foundation, Musculoskeletal Tumor Society.

Asian Cancer Societies: Association of Radiation Oncologists of India, Japanese Breast Cancer Society, Asian Cancer Foundation, Japan Lung Cancer Society, Cancer Relief Society Nepal.

Track 3: Radiology & Imaging in Cancer Diagnosis & Therapy

Radiation therapy uses great energy element or radiation or waves such as x-rays, gamma rays, electron beams, protons to abolish or shrink Cancer cell. When compared to normal cell, the Cancer cells grow and split faster, radiation works by making minor breaks in the DNA inside the cells. Cancer cells whose DNA is damaged by radiation stops dividing or die. The normal cell current nearby Cancer cells can also be affected by radiation, leading to side effects. Radiation therapy may be used alone or in combination with surgery Immunotherapy and Chemotherapy. The radiation can be given in 3 ways dependent upon the type of Cancer and position. Types of radiation are external radiation, internal radiation, systemic radiation and others.

Cancer Imaging is the term that covers many methods used in diagnoses and Research Cancer. It is initially used to diagnose and stage the disease and now it is also used to assist with surgery and Radiotherapy, to recognise patients who are responding to treatment and to look for early responses.

Endoscopy, Colonoscopy and Sigmoidoscopy
Imaging tests: X-ray, PET, CT, MRI, Mammography, ultrasound etc.
Nuclear medicine scans, bone scans, Fluoroscopy, SPECT and other methods

European Cancer Societies: Children's Cancer Association, French Society of Oncolog y Pharmacy, French Society of Oncology Pharmacy, Belgian Association of Oncological Radiotherapy, Cancer Registry Bavaria, European Cancer Organization.

USA Cancer Societies: National Cancer Institute, American Childhood Cancer Association, National Brain Tumor Society, American Cancer Society, Gynaecologic Oncology Group.

Asian Cancer Societies: Chinese Anti-Cancer Association, Japanese Breast Cancer Society, Japan Lung Cancer Society, Federation of Asian Organizations for Radiation Oncology, Asian Cancer Foundation.

Track 4: Cancer Genetics and Epigenetics

Cancer is basically a disease of tissue growth regulation. In order for a normal cell to transform into a Cancer cell, the genes that control cell growth and variation must be altered. The affected genes are divided into two broad categories: Oncogenes and Tumor Suppressor Genes. Oncogenes are genes that stimulate cell growth and reproduction. Tumor Suppressor Genes are genes that prevent cell division and survival. Malignant alteration can arise through the development of novel Oncogenes, the unfortunate over-expression of typical Oncogenes, or by the under-expression or inactivating of Tumor Suppressor Genes. Usually, alterations in Multiple Genes are essential to transform a normal cell into a Cancer cell.

Cancer Epigenetics deals with the Epigenetic Alterations to the genome of Cancer cells that do not comprise any change in the nucleotide sequence. Epigenetic Alterations are as vital as Genetic Mutations in a normal cell conversion to Cancer cells, and their manipulation holds great promise for Cancer prevention, detection, and therapy.

Track 5: Nanotechnology in Cancer Treatment

The Nanoparticles or Nanotechnology in Cancer Treatment deals with destruction, detection, and elimination of the cancer cells with minimal harm to the healthy tissue present near. Nanoparticles are inoculated directly into the cancer cells and can destroy the proliferation of the Cancer cell present inside. Nanoparticle plays major role in drug delivery to overcome the limits of conventional treatment methods.

Delivering life through chemotherapy
Nano therapy for Cancer
Augmenting radiotherapy

USA Cancer Societies: National Cancer Institute, American Childhood Cancer Association, National Brain Tumor Society, American Cancer Society, Gynaecologic Oncology Group.

Asian Cancer Societies: Chinese Anti-Cancer Association, Japanese Breast Cancer Society, Japan Lung Cancer Society, Federation of Asian Organizations for Radiation Oncology, Asian Cancer Foundation

Track 6: Cancer Preventive Vaccines: Oncolytic Therapy & Others

Cancer vaccines stimulate the immune system’s capability to protect the body against the infectious agents that may cause disease. Cancer vaccine is also known as biological response modifiers. There are two types of cancer vaccine: Preventive vaccine and treatment vaccine. The Preventive vaccine is used to stop the development of the Cancer cell and treatment vaccines are used to treat the existing cancer by natural immune system to fight against the cancer.

Oncolytic Virus is a virus that infects and breakdown Cancer cells but not normal cells. Oncolytic virus therapy may make it easier to kill tumor cells with chemotherapy and radiation therapy. It is a type of targeted therapy. Also called oncolytic virotherapy, viral therapy, and virotherapy.

Cancer Cell Mechanisms
Cancer Clinical trials
Cancer Epidemiology
Cancer Biostatistics
Medical Oncology
Interpretive Oncology

Track 7: Precision Medicine and Immuno-Oncology

Precision medicine or personalized medicine is an approach to individual care for selecting treatment that are helpful to the patients based on a genetic understanding of their disease. Depending upon the type of cancer, its size and proliferation, combination of Treatment surgery, Chemotherapy, Radiation therapy and Immunotherapy may vary. But in precision medicine, information about genetic changes in the tumor can be helping to decide the Treatment.

Cancer Immunology is concerned with Immune system in progression and development of Cancer. The most well-known application is Cancer Immunotherapy where the immune system is used to treat cancer.

Novel concepts in Bi-specific Antibodies Engineering
Pre-clinical and Translational Immuno-Oncology Developments
Personalized Immunotherapy, Combination Immunotherapy and Viral Therapies

Track 8: Circulating Tumor Cell (CTC)

Circulating Tumor Cell are the cells that are shed into the lymphatic or vasculature stream from a tumor and remain loose in circulation, cluster together as they travel or lodge themselves in new tissues. The detection of Circulating tumor cell has important Diagnostic and Therapeutic implication then their number can be very small and cells are not certainly identified.

Methods of CTC detection
CTC number as a surrogate response and prognostic biomarker
CTC chip technology and EGFR mutation analysis
Application of CTC technologies to clinical testing

Track 9: Cell and Gene Therapy for Cancer

Cell Therapy goes for focusing on different diseases at the cellular level, i.e. by re-establishing a definite cell populace or using cells as therapeutic cargo. Gene Therapy deals with biomedical investigation with the objective of impacting the course of different hereditary and procured diseases at the DNA/RNA level. For utmost diseases, cell and gene therapy are applied in combination. Moreover, these two fields have given ideas, reagents, and techniques that are lighting up the improved purposes of quality control, stem cell lineage, cell-cell interactions, input circles, enhancement circles, regenerative limit, and redesigning or remodeling.

Understanding of the genetic basis of cancer
Developed methods for isolating, expanding and engineering cancer-killing cells
Enhancing the immunogenicity of the tumor by introducing genes therapy

Track 10: Targeted Cancer Therapy

Targeted Cancer Therapy is one of the chief means of medical treatment for Cancer. Targeted Therapy blocks the development of Cancer cells by interfering with Specific Targeted Molecules required for carcinogenesis and tumor growth rather than by simply interfering with all rapidly dividing cells. Targeted Cancer Therapies are likely to be more effective than older forms of treatments and less harmful to normal cells. Numerous Targeted Therapies are examples of immunotherapy using immune mechanisms for therapeutic purposes developed by the field of cancer immunology. So, as immunomodulators, they are one type of biological response modifiers.

FDA approved Targeted Therapies for Cancer
Monoclonal Antibody-conjugated Nanoparticles for Targeted Cancer Therapy
Types of targeted therapies: hormone therapies, signal transduction inhibitors, expression modulators, apoptosis inducers, angiogenesis inhibitors, toxin delivery molecules etc.
Molecular targeted therapies

Track 11: Cancer Clinical Trials

Clinical trials for cancer are research studies that relate the most effective well-known treatment for a specific type or stage of cancer with a novel approach. This can be a new drug, or combination of drugs or a unlike way of using established therapies. There are trials that comprise new approaches to surgery and radiation treatment. There are clinical trials for each type of cancer. Though many trials focus on late stage disease, there are also trials to prevent cancer, improve early diagnosis, stop the cancer from coming back, reduce side effects or improve quality of life.

Cryoablation
Hematopoietic Stem cell therapy
Stem Cell Transplantation
Chemotherapy

Cancer Societies: Cancer Support Community , International Cancer Alliance for Research and Education, Bladder Cancer Advocacy Network,American Brain Tumor Association,American Childhood Cancer Organization ,

Track 13: Cancer Biology and Drug Delivery

A term for diseases in which abnormal cells divide without control and can attack nearby tissues. Cancer cells can also spread to new parts of the body through the blood and lymph systems. There are numerous main types of cancer. Carcinoma is a cancer that originates in the skin or in tissues that line or cover interior organs. Sarcoma is a cancer that originates in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. Leukemia is a cancer that starts in blood-forming tissue, such as the bone marrow, and causes large amounts of abnormal blood cells to be produced and enter the blood. Lymphoma and multiple myeloma are cancers that arise in the cells of the immune system. Central nervous system cancers are cancers that arise in the tissues of the brain and spinal cord they are also called malignancy.

Medication conveyance refers to plans, approaches, advances, and frameworks for carrying a pharmaceutical compound in the body as estimated to securely achieve its desired curative effect. It might contain logical site-focusing inside the body, or it may include encouraging fundamental pharmacokinetics; regardless, it is commonly worried about both amount and length of medication nearness. Medication conveyance is commonly drawn closer by means of a medication's synthetic definition.

Hospice in cancer
Radiation Therapy
Precision Medicine
Immunotherapy

Track 14: Cancer Pharma Industry

Cancer is one of the best wellbeing challenges, and a chief cause of death in each edge of the world. The international market for Cancer drugs is anticipated to develop twice as quick as that of different pharmaceuticals throughout the following couple of years.Top organizations incorporate Janssen biotech, Boehringer ingelheim, Roche, Celgene, Takeda oncology, Novartis, Johnson and Johnson, and Amgen. The growth business is the most usually profitable business in the USA. It has been seen that, there are 1,665,540 novel malignancy cases analyzed and 585,720 growths short-lived in the US in the year 2014. $6 billion of citizen stores are turned through different government organizations for malignancy explore for the most part as the National Cancer Institute . The NCI states that the restorative expenses of disease mind are $125 billion, with the ascent of 39 percent to $173 billion by the up and coming year that is 2022. The most renowned maxim of the growth business is it exploits an excessive number of individuals and delivers excessively pay to enable a cure to be found.

Patient Assessment & Education
Management & Palliative Care
Treatment Plans
Supportive Care

Cancer Societies: Association of Oncology Social Work , Bone Marrow & Cancer Foundation , Cancer Hope Network ,Cancer Legal Resource Center , Cancer Research and Prevention Foundation,Head and Neck Cancer Alliance ,Inflammatory Breast Cancer Research Foundation , Intercultural Cancer Council , France Meetings , Kidney Cancer Association

Track 15: Alternative Treatment and Cancer Therapy

Cancer can be treated by many methods, such as surgery, chemotherapy, radiation therapy, targeted therapy, hormonal therapy, and synthetic lethality. People suffering from cancer can be examined through medical tests. These generally include blood tests are X-rays, CT scans, and endoscopy. The tissue investigation from the biopsy specifies the type of cell that multiplies, through its histological grade, genetic abnormalities, and other features. Thus all together it gives the user information about molecular changes such as mutations, fusion genes, and numerical chromosome to estimate or show the prognosis and to choose the best treatment. Cytogenetics and immunohistochemistry are other common tissue tests. The elimination of cancer without damaging the other parts of the body (by achieving cure with near-zero adverse effects) is the key goal of treatment. The type of treatment depends on the type of cancer the patient is suffering with and how advanced it is. Various people with cancer have only one type of treatment. But for maximum of the people, they have a combination of treatments, such as surgery with chemotherapy (use of drugs to kill cancer cells) or radiation therapy. Immunotherapy, targeted therapy, or hormone therapy are alternative kind of treatment for cancer.

Avoiding Risk Factors
Changing Lifestyle Choices
Preclinical & Clinical Research
Disfigurement

Track 16: Novel Approaches to Cancer Treatment

The usual treatment modalities are associated with severe side effects and high toxicity which in turn lead to low quality of life. This analysis encompasses novel strategies for more effective chemotherapeutic delivery aiming to generate better prognosis. Presently, cancer management is a highly dynamic field and significant advances are being made in the growth of novel cancer treatment strategies. In contrast to conventional cancer therapeutics, novel methods such as ligand or receptor based targeting, intracellular drug targeting, gene delivery, cancer stem cell therapy, magnetic drug targeting and ultrasound-mediated drug delivery, have added novel modalities for cancer treatment.

Advanced laparoscopic surgery
ovarian cancer
vaginal cancer
vulvar cancer

Cancer Societies: Native American Cancer Research , Oncology Nursing Society , Oral Cancer Foundation , Ovarian Cancer National Alliance , Skin Cancer Foundation, Cancer Research and Prevention Foundation,Head and Neck Cancer Alliance ,Inflammatory Breast Cancer Research Foundation , Intercultural Cancer Council , France Meetings , Kidney Cancer Association

Track 17: Anti-Cancer Drug Discovery and Development

Drug discovery and development together are the complete practice of identifying a new drug and passing it to market. Discovery might include screening of chemical libraries, identification of the active ingredient from a natural remedy or design resulting from an understanding of the target.

Advanced laparoscopic surgery
ovarian cancer
vaginal cancer
vulvar cancer

Thyroid Cancer Conferences | Uterine Cancer Conferences | Vulvar and Vaginal Cancer Conferences | Colorectal Cancer Conferences

Track 18: Cancer immunotherapy: Car T Cell Technology

A type of treatment in which a patient’s T cells (a type of immune cell) are altered in the laboratory so they will bind to cancer cells and destroy them. Blood from a vein in the patient’s arm flows through a tube to an apheresis machine (not shown), which eliminates the white blood cells, including the T cells, and directs the rest of the blood back to the patient. Then, the gene for a special receptor named a chimeric antigen receptor (CAR) is introduced into the T cells in the laboratory. Millions of the CAR T cells are developed in the laboratory and then given to the patient by infusion. The CAR T cells are able to bind to an antigen on the cancer cells and destroy them.

CAR-T cell therapy in acute lymphoblastic leukaemia
CAR-T cells therapy in chronic lymphocytic leukaemia
CAR-T cell in multiple myeloma

Thyroid Cancer Conferences | Uterine Cancer Conferences | Vulvar and Vaginal Cancer Conferences | Colorectal Cancer Conferences

Market Analysis

Note: Global Cancer will be the best platform for all the scientist, radiologists, oncologists, research scholars, students who are working in this field to exchange their knowledge related to Cancer and oncology. This international event is an effort to find an alternative for invasive imaging technique against cancer like Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Cancer in adults & cancer in children

Market Analysis:

Cancer is the name given to a collection of related diseases. In all types of cancer, some of the body’s cells begin to divide without stopping and spread into surrounding tissues. Cancer can start almost anywhere in the human body, which is made up of trillions of cells. Normally, human cells grow and divide to form new cells as the body needs them. When cells grow old or become damaged, they die, and new cells take their place. When cancer develops, however, this orderly process breaks down. As cells become more and more abnormal, old or damaged cells survive when they should die, and new cells form when they are not needed. These extra cells can divide without stopping and may form growths called tumors.

Importance and Scope:

2019 Global Cancer will be the best platform for all the scientist, radiologists, oncologists, research scholars, students who are working in this field to exchange their knowledge related to Cancer and oncology. This international event is an effort to find an alternative for invasive imaging technique against cancer like Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Cancer in adults & cancer in children.

North America is the leading regional marketplace for cancer diagnostics with a part of approximately 40.7% of the general cancer diagnostics market in terms of income in 2015, shadowed by Europe which accounted for around 29.1% share in the market.

Major Cancer Associations:

Worldwide:

American Association for Cancer Research
Virginia Cancer Institute
American Brain Tumor Association
American Society of Pediatric Hematology/Oncology
Association of Cancer Physicians
American Childhood Cancer Organization
American Society of Clinical Oncology
Australasian Lung Cancer Trials Group
International Cancer Research Partnership (ICRP)
American Association for Cancer Research (AACR)
American Society of Clinical Oncology (ASCO)
International Agency for Research on Cancer (IARC)
Cancer Society of New Zealand
Irish Cancer Society
Australian Cervical Cancer Foundation
Medical Centre Cologne
Cancer Research UK
Australian Prostate Cancer Research
Peter McCollum Cancer Centre
The European Cancer Organization (ECCO)
German Cancer Research Centre

In Asia Pacific:

Medical Excellence JAPAN
Japan Community Health care Organization Chukyo Hospital
Aichi Cancer Center Hospital
Japanese Red Cross Nagoya Daiichi Hospital
Kyoto University Hospital
Dokkyo Medical University Hospital
Japan Hospital Association
Aizawa Hospital

Major Medical Universities:

Worldwide:

Emory University
Karolinska University
University of Cambridge
University of Oxford Stanford University
UNC School of Medicine
Harvard University
Mayo Medical School
Yale University
University of Minnesota
John Hopkins University
Pittsburgh School of Medicine
University of Wisconsin
Kings College London
Feinberg School of Medicine

In Asia Pacific:

The University of Tokyo
University of Delhi
KAIST - Korea Advanced Institute of Science and Technology
National University of Singapore (NUS)
Kyoto University
University of Hong Kong (HKU)
Peking University
Seoul National University (SNU)
National Taiwan University (NTU)
Osaka University
Tsinghua University0
The Chinese University of Hong Kong (CUHK)
Fudan University
The Hong Kong University of Science and Technology (HKUST)
Shanghai Jiao Tong University
Mahidol University
Korea University
Beijing University of Chinese Medicine
Taipei Medical University
Beijing Institute of Technology
Yonsei University
Nanyang Technological University (NTU)
Chulalongkorn University
Tohoku University
Tokyo Medical and Dental University
Kyushu University
Nagoya University
Hokkaido University
Sungkyunkwan University
University of Science and Technology of China
Pohang University of Science and Technology (POSTECH)
Universiti Malaya (UM)
Zhejiang University
Keio University
Indian Institute of Science
Tokyo Institute of Technology
Universiti Kebangsaan Malaysia (UKM)
Universiti Sains Malaysia (USM)
Nanjing University
Kyung Hee University
National Yang Ming University
University of Indonesia
University of the Philippines
University of Tsukuba
Bandung Institute of Technology (ITB)
Hanyang University
Indian Institute of Technology Bombay (IITB)
National Cheng Kung University
Universiti Putra Malaysia (UPM)

Target Audience: Oncologists, Radiologists, Immunologists, Clinical Researchers, Doctors, Researchers, Youthful Researchers, Undergraduates, Business Entrepreneurs, Brand Manufacturers/ Marketers of Consumer Products, Pharmaceutical Companies and Diagnostics Companies

Past Conference Report

Cancer Research 2023

19^th International Conference on Cancer Research was organized on March 27-28, 2023 London, UK. Cancer Research 2023 has received a generous response from all over the world. This has been organized with the aim of endorsing the development of new perceptions and ideas for investigating the high level of knowledge reached by scientific community on Cancer Research.

This conference brought together the Leading Biochemists, Researchers, Clinicians, Professors, Specialists, Students and other professionals in which many issues in Cancer field were discussed in depth to provide up-to-date information to the world. On the other hand, the meeting provided an opportunity for networking.

Conference series llc LTD takes its pleasure to thank all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Partners and all who supported the conference in every aspect for the magnificent presence at the venue.

Conference Series llc LTD is overwhelmed to announce the expertconferences.org of its 20^th International Conference on Cancer Research organized around the theme “Cancer Research Strengthening the feature to fight against Cancer”. The conference is CME Accredited.

We would like to inquire your cordial existence.

For More details: Cancer Research 2024

Past Reports Gallery

To Collaborate Scientific Professionals around the World

Conference Date March 18-19, 2024

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Poster Opportunity E-Poster Opportunity

Useful Links

Past Conference Report

Cancer Research 2023 Conference

Supported By

Journal of Integrative Oncology Journal of Tumour Research & Reports Journal of Cancer Science & Therapy

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Cancer Research

March 18-19, 2024 Zurich, Switzerland

Cancer Conferences | Cancer Research | Medicinal Cancer Research Conferences | Conferenceseries | 2024

Conference Series Conferences gaining more Readers and Visitors

Renowned Speakers

Vitor H. Pomin

Adrian Senderowicz

Nikhil Mukhi

Niccola Funel

Jianchang Yang

B R Das

Vincent Balaya

Xudong Miao

Recommended Global Medical Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

Cancer Research 2024

About Conference

Sessions/Tracks

Market Analysis

Past Conference Report

To Collaborate Scientific Professionals around the World

Useful Links

Past Conference Report

Supported By